These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22648)

  • 1. On representation and interpretation of drug displacement interactions [proceedings].
    Aarons LJ; Schary WL; Rowland M
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():2P. PubMed ID: 22648
    [No Abstract]   [Full Text] [Related]  

  • 2. Representation and interpretation of drug displacement interactions.
    Schary WL; Aarons LJ; Rowland M
    Biochem Pharmacol; 1978 Jan; 27(1):139-44. PubMed ID: 619901
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the true clinical significance of plasma protein binding displacement interactions?
    Sansom LN; Evans AM
    Drug Saf; 1995 Apr; 12(4):227-33. PubMed ID: 7646820
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein binding displacement interactions and their clinical importance.
    McElnay JC; D'Arcy PF
    Drugs; 1983 May; 25(5):495-513. PubMed ID: 6345130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of drug-protein binding.
    Gillette JR
    Ann N Y Acad Sci; 1973 Nov; 226():6-17. PubMed ID: 4588445
    [No Abstract]   [Full Text] [Related]  

  • 6. The application of basic principles of drug interaction to clinical practice.
    Robinson DS
    J Urol; 1975 Jan; 113(1):100-7. PubMed ID: 234541
    [No Abstract]   [Full Text] [Related]  

  • 7. Theoretic aspects of pharmacokinetic drug interactions.
    Gillette JR; Pang KS
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):623-39. PubMed ID: 913029
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Theoretical considerations of drug-protein binding.
    Krasner J
    Rev Can Biol; 1973; 32():Suppl:133-4. PubMed ID: 4777594
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of receptor interactions using binding methods.
    Lazareno S
    J Recept Signal Transduct Res; 2001; 21(2-3):139-65. PubMed ID: 11757681
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-protein interactions and their clinical significance.
    Gabourel JD
    Adv Biol Skin; 1972; 12():51-60. PubMed ID: 4579205
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of in vitro human metabolism studies in drug development. An industrial perspective.
    Rodrigues AD
    Biochem Pharmacol; 1994 Dec; 48(12):2147-56. PubMed ID: 7811296
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug--drug interactions. A general discussion about how and where drugs may interact in the body.
    Palmer JD; Bressler R
    Ariz Med; 1974 Feb; 31(2):89-93. PubMed ID: 4816223
    [No Abstract]   [Full Text] [Related]  

  • 13. Displacement of Drugs from Human Serum Albumin: From Molecular Interactions to Clinical Significance.
    Rimac H; Debeljak Ž; Bojić M; Miller L
    Curr Med Chem; 2017; 24(18):1930-1947. PubMed ID: 28155602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology: plasma protein binding of drugs.
    Lindup WE; Orme MC
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):212-4. PubMed ID: 6779954
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data.
    Christensen H; Baker M; Tucker GT; Rostami-Hodjegan A
    J Pharm Sci; 2006 Dec; 95(12):2778-87. PubMed ID: 16937340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic consequences of drug displacement from blood and tissue proteins.
    MacKichan JJ
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():32-41. PubMed ID: 6705425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANS-drug interactions to AAG and HSA fluorescence and equilibrium dialysis studies.
    Essassi D; Zini R; Tillement JP
    Prog Clin Biol Res; 1989; 300():423-6. PubMed ID: 2780639
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug binding properties of an alpha-bungarotoxin-binding component from rat brain.
    Schmidt J
    Mol Pharmacol; 1977 Mar; 13(2):283-90. PubMed ID: 854024
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved parameter estimates in drug-protein binding studies by non-linear regression.
    Madsen BW; Robertson JS
    J Pharm Pharmacol; 1974 Oct; 26(10):807-13. PubMed ID: 4156539
    [No Abstract]   [Full Text] [Related]  

  • 20. Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.
    Koch G; Jusko WJ; Schropp J
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):27-42. PubMed ID: 28074396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.